Comon allelic variants of cytochrome P4503A and their prevalence in different populations

被引:46
|
作者
Maradiegue, Ann
Edwards, Quannetta T.
机构
[1] George Mason Univ, Coll Nursing & Hlth Sci, Falls Church, VA 22046 USA
[2] Howard Univ, Coll Pharm Nursing & Allied Hlth, Washington, DC 20059 USA
来源
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS | 2006年 / 18卷 / 10期
关键词
ethnicity; race; ancestry; family history; genetics; health disparities;
D O I
10.1111/j.1745-7599.2006.00156.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: To discuss the importance of and the nurse practitioner's (NP's) role in the assessment of ethnicity/family of origin in conducting a multigenerational family history in primary care settings. Data sources: A review of the literature on past research results addressing racial and ethnic disparities and current articles from scientific journals exploring the relationship between race and genetics. Web sites were from the National Institutes of Health, the Human Genome Research Institute, the National Cancer Institute, and the Health and Human Services Minority Health and Disparities report. Conclusions:The family history has received renewed interest due to the sequencing of the human genome. A multigenerational family history is an important first step in screening for a multitude of disorders impacted by genetic susceptibility, shared environments, and common behaviors. Assessment of the patient's ethnicity/family of origin is an integral part of the multigenerational family history, particularly in the diagnosis of chronic diseases and the assessment of risks for genetic disorders. The multigenerational family history is important in diagnosis, predictive genetic testing, disease prevention, and health promotion. Challenges facing NPs and the utilization of a multigenerational family history in the current U.S. health system include (a) training clinicians on the correct assessment and utilization of a multigenerational family history, (b) assessment of the subtleties of ethnicity and identifying multiple ethnic groups within a family, (c) collection of the family history in a manner that is sensitive to the cultural beliefs of individuals, and (d) avoidance of stereotyping Implictions for practice: Significant advances in genetics and genetic testing requires that NPs be well versed in collecting and interpreting a multigenerational family history to include assessment of the patient/family's ethnicity/family of origin. The ability to effectively conduct and evaluate the individual's and family's health risk through a multigenerational family history will be important in diagnosis, health promotion, disease prevention, and the determination for genetic counseling referral and predictive testing when appropriate. Assessment of risk and prevention of disease is also important in reducing health disparities.
引用
收藏
页码:447 / 456
页数:10
相关论文
共 50 条
  • [21] An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity
    Rogers, JF
    Rocci, ML
    Haughey, DB
    Bertino, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (03) : 153 - 158
  • [22] The mycotoxin T-2 inhibits hepatic cytochrome P4503A activity in pigs
    Goossens, J.
    De Bock, L.
    Osselaere, A.
    Verbrugghe, E.
    Devreese, M.
    Boussery, K.
    Van Bocxlaer, J.
    De Backer, P.
    Croubels, S.
    FOOD AND CHEMICAL TOXICOLOGY, 2013, 57 : 54 - 56
  • [23] Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite
    Pai H.V.
    Upadhya S.C.
    Chinta S.J.
    Hegde S.N.
    Ravindranath V.
    The Pharmacogenomics Journal, 2002, 2 (4) : 243 - 258
  • [24] Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A
    Salphati, L
    Benet, LZ
    XENOBIOTICA, 1999, 29 (02) : 171 - 185
  • [25] Cytochrome P4503A (CYP3A) metabolism: Prediction of in vivo activity in humans
    Wilkinson, GR
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1996, 24 (05): : 475 - 490
  • [26] Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A
    Kinirons, MT
    O'Shea, D
    Kim, RB
    Groopman, JD
    Thummel, KE
    Wood, JJ
    Wilkinson, GR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) : 224 - 231
  • [27] Cytochrome P4503A Does Not Mediate the Interaction between Methadone and Ritonavir-Lopinavir
    Kharasch, Evan D.
    Stubbert, Kristi
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2166 - 2174
  • [28] Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes
    Basheer, Loai
    Schultz, Keren
    Fichman, Merav
    Kerem, Zohar
    PLOS ONE, 2015, 10 (10):
  • [29] Detection of cytochrome P4503A (CYP3A) in human hepatic stellate cells
    Parola, M
    Robino, G
    Bordone, R
    Leonarduzzi, G
    Casini, A
    Pinzani, M
    Neve, E
    Bellomo, G
    Dianzani, MU
    IngelmanSundberg, M
    Albano, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (02) : 420 - 424
  • [30] HUMAN LIVER CYTOCHROME P4503A BIOTRANSFORMATION OF THE CYCLOSPORINE DERIVATIVE SDZ IMM-125
    VICKERS, AEM
    MEYER, E
    DANNECKER, R
    KELLER, B
    TYNES, RE
    MAURER, G
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (03) : 321 - 326